Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions

BMC Microbiology

Volumn 10, Issue , 2010, Pages

  Garbe, Julia ^a   Wesche, Andrea ^a   Bunk, Boyke ^a   Kazmierczak, Marlon ^b   Selezska, Katherina ^c   Rohde, Christine ^b   Sikorski, Johannes ^b   Rohde, Manfred ^c   Jahn, Dieter ^a   Schobert, Max ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; LIPOPOLYSACCHARIDE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIOPHAGE; CHRONIC DISEASE; CYSTIC FIBROSIS; EXPERIMENT; GENE SEQUENCE; GENETIC DISORDER; GENETICS; GENOME; HOST RANGE; LUNG INFECTION; NONHUMAN; OPEN READING FRAME; PSEUDOMONAS AERUGINOSA; SPUTUM; SPUTUM EXAMINATION; BIOLOGICAL MODEL; BIOLOGICAL THERAPY; HUMAN; LUNG DISEASE; MICROBIOLOGY; PHYSIOLOGY; PSEUDOMONAS INFECTION; VIROLOGY; VIRUS GENOME;

PSEUDOMONAS AERUGINOSA;

BACTERIOPHAGES; BIOLOGICAL THERAPY; CYSTIC FIBROSIS; GENOME, VIRAL; HOST SPECIFICITY; HUMANS; LUNG DISEASES; MODELS, BIOLOGICAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM;

EID: 78649316387     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-10-301     Document Type: Article

References (50)

1. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. HP Schweizer, Genet Mol Res 2003 2 48 62 12917802
2. Lung infections associated with cystic fibrosis. JB Lyczak CL Cannon GB Pier, Clin Microbiol Rev 2002 15 194 222 10.1128/CMR.15.2.194-222.2002 11932230
3. Characteristics of Pseudomonas aeruginosa strains isolated from urinary tract infections. H Puzov L Siegfried M Kmetov J Durovicov A Kerestesov Folia Microbiol (Praha) 1994 39 337 341 10.1007/BF02814324 7729771
4. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. RT Sadikot TS Blackwell JW Christman AS Prince, Am J Respir Crit Care Med 2005 171 1209 1223 10.1164/rccm.200408-1044SO 15695491
5. Burn wound infections. D Church S Elsayed O Reid B Winston R Lindsay, Clin Microbiol Rev 2006 19 403 434 10.1128/CMR.19.2.403-434.2006 16614255
6. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. VL Campodánico M Gadjeva C Paradis-Bleau A Uluer GB Pier, Trends Mol Med 2008 14 120 133 18262467
7. Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease. G Döring E Gulbins, Cell Microbiol 2009 11 208 216 10.1111/j.1462-5822.2008.01271.x 19068098
8. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. JR Riordan JM Rommens B Kerem N Alon R Rozmahel Z Grzelczak J Zielenski S Lok N Plavsic JL Chou, Science 1989 245 1066 1073 10.1126/science.2475911 2475911 (Pubitemid 19231814)
9. Quorum-sensing signals indicate that cystic brosis lungs are infected with bacterial biofilms. PK Singh AL Schaefer MR Parsek TO Moninger MJ Welsh EP Greenberg, Nature 2000 407 762 764 10.1038/35037627 11048725
10. Mechanisms of biofilm resistance to antimicrobial agents. TF Mah GA O'Toole, Trends Microbiol 2001 9 34 39 10.1016/S0966-842X(00)01913-2 11166241
11. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. KL Palmer LM Mashburn PK Singh M Whiteley, J Bacteriol 2005 187 5267 5277 10.1128/JB.187.15.5267-5277.2005 16030221
12. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic brosis lung. DD Sriramulu H Lünsdorf JS Lam U Römling, J Med Microbiol 2005 54 667 676 10.1099/jmm.0.45969-0 15947432
13. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. H Matsui VE Wagner DB Hill UE Schwab TD Rogers B Button RM Taylor R Superfine M Rubinstein BH Iglewski RC Boucher, Proc Natl Acad Sci USA 2006 103 18131 18136 10.1073/pnas.0606428103 17116883
14. Bacteriophage therapy. A Sulakvelidze Z Alavidze JG Morris, Antimicrob Agents Chemother 2001 45 649 659 10.1128/AAC.45.3.649-659.2001 11181338
15. Comparative analysis of the widespread and conserved PB1-like viruses infecting Pseudomonas aeruginosa. P Ceyssens K Miroshnikov W Mattheus V Krylov J Robben J Noben S Vanderschraeghe N Sykilinda A Kropinski G Volckaert V Mesyanzhinov R Lavigne, Environ Microbiol 2009 11 2874 2883 10.1111/j.1462-2920. 2009.02030.x 19678828
16. DNA homology in species of bacteriophages active on Pseudomonas aeruginosa. VN Krylov TO Tolmachova VZ Akhverdian, Arch Virol 1993 131 141 151 10.1007/BF01379086 8328909
17. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. M Merabishvili JP Pirnay G Verbeken N Chanishvili M Tediashvili N Lashkhi T Glonti V Krylov J Mast LV Parys R Lavigne G Volckaert W Mattheus G Verween PD Corte T Rose S Jennes M Zizi DD Vos M Vaneechoutte, PLoS ONE 2009 4 4944 10.1371/journal.pone.0004944 19300511
18. Phage therapy: facts and fiction. M Skurnik E Strauch, Int J Med Microbiol 2006 296 5 14 10.1016/j.ijmm.2005.09.002 16423684
19. Population and evolutionary dynamics of phage therapy. BR Levin JJ Bull, Nat Rev Micro 2004 2 166 173 10.1038/nrmicro822 (Pubitemid 39490070)
20. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. DW Martin MJ Schurr MH Mudd JR Govan BW Holloway V Deretic, Proc Natl Acad Sci USA 1993 90 8377 8381 10.1073/pnas.90.18.8377 8378309
21. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. DJ Hassett MD Sutton MJ Schurr AB Herr CC Caldwell JO Matu, Trends Microbiol 2009 17 130 138 10.1016/j.tim.2008.12.003 19231190
22. 5500 Phages examined in the electron microscope. HW Ackermann, Arch Virol 2007 152 227 243 10.1007/s00705-006-0849-1 17051420
23. Isolation and characterization of a generalized transducing phage for Pseudomonas aeruginosa strains PAO1 and PA14. JM Budzik WA Rosche A Rietsch GA O'Toole, J Bacteriol 2004 186 3270 3273 10.1128/JB.186.10.3270-3273.2004 15126493
24. The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core. MJ Coyne KS Russell CL Coyle JB Goldberg, J Bacteriol 1994 176 3500 3507 7515870
25. Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. J King D Kocíncov E Westman J Lam, Innate Immun 2009 15 261 312 10.1177/1753425909106436 19710102
26. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. SF Altschul TL Madden AA Schäffer J Zhang Z Zhang W Miller DJ Lipman, Nucleic Acids Res 1997 25 3389 3402 10.1093/nar/25.17.3389 9254694
27. Mauve: multiple alignment of conserved genomic sequence with rearrangements. ACE Darling B Mau FR Blattner NT Perna, Genome Res 2004 14 1394 1403 10.1101/gr.2289704 15231754
28. Identification of the cell wall receptor for bacteriophage E79 in Pseudomonas aeruginosa strain PAO. K Jarrell AM Kropinski, J Virol 1977 23 461 466 408513
29. tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence. TM Lowe SR Eddy, Nucleic Acids Res 1997 25 955 964 10.1093/nar/25.5.955 9023104
30. Complete nucleotide sequence, molecular analysis and genome structure of bacteriophage A118 of Listeria monocytogenes: implications for phage evolution. MJ Loessner RB Inman P Lauer R Calendar, Mol Microbiol 2000 35 324 340 10.1046/j.1365-2958.2000.01720.x 10652093
31. Heuristic approach to deriving models for gene finding. J Besemer M Borodovsky, Nucleic Acids Res 1999 27 3911 3920 10.1093/nar/27.19.3911 10481031
32. Database resources of the National Center for Biotechnology. DL Wheeler DM Church S Federhen AE Lash TL Madden JU Pontius GD Schuler LM Schriml E Sequeira TA Tatusova L Wagner, Nucleic Acids Res 2003 31 28 33 10.1093/nar/gkg033 12519941
33. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. A Bragonzi D Worlitzsch GB Pier P Timpert M Ulrich M Hentzer JB Andersen M Givskov M Conese G Doring, J Infect Dis 2005 192 410 419 10.1086/431516 15995954 (Pubitemid 41023119)
34. Genetic mapping of chromosomal determinants for the production of the exopolysaccharide alginate in a Pseudomonas aeruginosa cystic fibrosis isolate. DE Ohman AM Chakrabarty, Infect Immun 1981 33 142 148 6790439
35. Extracellular enzymes affect biofilm formation of mucoid Pseudomonas aeruginosa. P Tielen F Rosenau S Wilhelm KE Jaeger HC Flemming J Wingender, Microbiology 2010 156 2239 2252 10.1099/mic.0.037036-0 20360178
36. Isolation and biochemical characterization of extracellular polymeric substances from Pseudomonas aeruginosa. J Wingender M Strathmann A Rode A Leis HC Flemming, Meth Enzymol 2001 336 302 314 10.1016/S0076-6879(01)36597-7 11398408
37. Population structure of Pseudomonas aeruginosa. L Wiehlmann G Wagner N Cramer B Siebert P Gudowius G Morales T Kohler C van Delden C Weinel P Slickers B Tummler, Proc Natl Acad Sci USA 2007 104 8101 8106 10.1073/pnas.0609213104 17468398
38. Isolation of Pseudomonas aeruginosa specific phages with broad activity spectra. P Knezevic R Kostanjsek D Obreht O Petrovic, Curr Microbiol 2009 59 173 180 10.1007/s00284-009-9417-8 19472004
39. Molecular cloning and characterization of the rfc gene of Pseudomonas aeruginosa (serotype O5). TR de Kievit T Dasgupta H Schweizer JS Lam, Mol Microbiol 1995 16 565 574 10.1111/j.1365-2958.1995.tb02419.x 7565115
40. Bacteriophage phiYeO3-12, specific for Yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. M Pajunen S Kiljunen M Skurnik, J Bacteriol 2000 182 5114 5120 10.1128/JB.182.18.5114-5120.2000 10960095
41. Differentiation of Two Abortive Mechanisms by Using Monoclonal Antibodies Directed toward Lactococcal Bacteriophage Capsid Proteins. S Moineau E Durmaz S Pandian TR Klaenhammer, Appl Environ Microbiol 1993 59 208 212 16348844
42. Clustal W and Clustal × version 2.0. MA Larkin G Blackshields NP Brown R Chenna PA McGettigan H McWilliam F Valentin IM Wallace A Wilm R Lopez JD Thompson TJ Gibson DG Higgins, Bioinformatics 2007 23 2947 2948 10.1093/bioinformatics/btm404 17846036
43. JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. A Grote K Hiller M Scheer R Munch B Nörtemann DC Hempel D Jahn, Nucleic Acids Res 2005 33 526 531 10.1093/nar/gki376 15980527
44. Sequence alignment kernel for recognition of promoter regions. L Gordon AY Chervonenkis AJ Gammerman IA Shahmuradov VV Solovyev, Bioinformatics 2003 19 1964 1971 10.1093/bioinformatics/btg265 14555630
45. Virtual Footprint and PRODORIC: an integrative framework for regulon prediction in prokaryotes. R Münch K Hiller A Grote M Scheer J Klein M Schobert D Jahn, Bioinformatics 2005 21 4187 4189 10.1093/bioinformatics/bti635 16109747
46. Prediction of transcription terminators in bacterial genomes. MD Ermolaeva HG Khalak O White HO Smith SL Salzberg, J Mol Biol 2000 301 27 33 10.1006/jmbi.2000.3836 10926490
47. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. TL Bailey C Elkan, Proc Int Conf Intell Syst Mol Biol 1994 2 28 36 7584402
48. Pleiotrophy of p-fluorophenylalanine-resistant and antibiotic hypersensitive mutants of Pseudomonas aeruginosa. NW Dunn BW Holloway, Genet Res 1971 18 185 197 10.1017/S0016672300012593 4258431
49. Common virulence factors for bacterial pathogenicity in plants and animals. LG Rahme EJ Stevens SF Wolfort J Shao RG Tompkins FM Ausubel, Science 1995 268 1899 1902 10.1126/science.7604262 7604262
50. Biofilm formation by Pseudomonas aeruginosa wild type, agella and type IV pili mutants. M Klausen A Heydorn P Ragas L Lambertsen A Aaes-Jørgensen S Molin T Tolker-Nielsen, Mol Microbiol 2003 48 1511 1524 10.1046/j.1365-2958. 2003.03525.x 12791135